🇺🇸 Cefazolin Injection in United States

64 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Infection — 24 reports (37.5%)
  2. Bacteraemia — 7 reports (10.94%)
  3. Treatment Failure — 7 reports (10.94%)
  4. Incision Site Infection — 6 reports (9.38%)
  5. Disease Progression — 4 reports (6.25%)
  6. Exposure During Pregnancy — 4 reports (6.25%)
  7. Clostridium Difficile Infection — 3 reports (4.69%)
  8. Disease Complication — 3 reports (4.69%)
  9. Drug-Induced Liver Injury — 3 reports (4.69%)
  10. No Adverse Event — 3 reports (4.69%)

Source database →

Cefazolin Injection in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Cefazolin Injection approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Cefazolin Injection in United States?

Abdul El-Rabbany is the originator. The local marketing authorisation holder may differ — check the official source linked above.